Achievement of Key Performance Targets under the Medium-Term Management Plan

「Although the spread of COVID-19 had a certain impact on performance in each business area of the medical equipment sales business during the fiscal year ending May 2021, the final year of the plan, all three final-year targets for consolidated revenue, consolidated operating profit and consolidated ordinary profit were achieved through strengthened sales activities in the core product areas and proactive proposals for COVID-19-related products, including infection-control equipment and various testing devices.」

「In July 2018, the Company formulated its current three-year medium-term management plan through the fiscal year ending May 2021. Its basic policy is to strengthen coordination among Group companies, enhance oversight of business execution, improve the Group’s profitability and expand its business fields. The key performance targets for the final year, the fiscal year ending May 2021, were consolidated revenue of ¥60,500 million, consolidated operating profit of ¥530 million and consolidated ordinary profit of ¥600 million. Despite a decline in revenue due to the impact of COVID-19 in the fourth quarter of the fiscal year ended May 2020, the Company achieved these key targets one year ahead of schedule.」